Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-06

Clinical Trial Update: S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate [Phase 3]

View source ↗

Summary

Phase 3 trial S9917 tested whether selenium could prevent cancer in men with prostate neoplasia; the study completed and posted results in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selenium (selenium)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Precancerous/Nonmalignant Condition, Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2013-02-06